The University of Chicago Header Logo

Connection

Eric Pamer to Humans

This is a "connection" page, showing publications Eric Pamer has written about Humans.
Connection Strength

1.259
  1. Translating Microbiome Research From and To the Clinic. Annu Rev Microbiol. 2022 09 08; 76:435-460.
    View in: PubMed
    Score: 0.028
  2. Microbiome-based therapeutics. Nat Rev Microbiol. 2022 06; 20(6):365-380.
    View in: PubMed
    Score: 0.028
  3. Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity. Cell Host Microbe. 2020 07 08; 28(1):134-146.e4.
    View in: PubMed
    Score: 0.025
  4. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019 08; 572(7771):665-669.
    View in: PubMed
    Score: 0.023
  5. Enlisting commensal microbes to resist antibiotic-resistant pathogens. J Exp Med. 2019 01 07; 216(1):10-19.
    View in: PubMed
    Score: 0.022
  6. Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them. Mucosal Immunol. 2019 01; 12(1):1-9.
    View in: PubMed
    Score: 0.022
  7. The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens. Immunol Rev. 2017 Sep; 279(1):90-105.
    View in: PubMed
    Score: 0.020
  8. Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Clostridium difficile Virulence. mBio. 2017 08 08; 8(4).
    View in: PubMed
    Score: 0.020
  9. Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections. Annu Rev Microbiol. 2017 09 08; 71:157-178.
    View in: PubMed
    Score: 0.020
  10. Bacterial pathogens: A spoonful of sugar could be the medicine. Nature. 2017 06 22; 546(7659):479-480.
    View in: PubMed
    Score: 0.020
  11. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med. 2017 Jul 03; 214(7):1973-1989.
    View in: PubMed
    Score: 0.020
  12. Microbial Tuning of the Mammalian Immune System. Trends Mol Med. 2017 05; 23(5):379-380.
    View in: PubMed
    Score: 0.020
  13. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016 10; 14(10):609-20.
    View in: PubMed
    Score: 0.019
  14. Gut Microbiota Predict Pulmonary Infiltrates after Allogeneic Hematopoietic Cell Transplantation. Am J Respir Crit Care Med. 2016 08 15; 194(4):450-63.
    View in: PubMed
    Score: 0.019
  15. Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates. Anaerobe. 2016 Oct; 41:32-36.
    View in: PubMed
    Score: 0.019
  16. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016 06; 22(6):458-478.
    View in: PubMed
    Score: 0.019
  17. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science. 2016 Apr 29; 352(6285):535-8.
    View in: PubMed
    Score: 0.019
  18. Microbiome mediation of infections in the cancer setting. Genome Med. 2016 Apr 18; 8(1):40.
    View in: PubMed
    Score: 0.019
  19. From Hype to Hope: The Gut Microbiota in Enteric Infectious Disease. Cell. 2015 Dec 03; 163(6):1326-32.
    View in: PubMed
    Score: 0.018
  20. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol. 2015 Jun-Sep; 28(2-3):155-61.
    View in: PubMed
    Score: 0.018
  21. Microbiota-mediated inflammation and antimicrobial defense in the intestine. Annu Rev Immunol. 2015; 33:227-56.
    View in: PubMed
    Score: 0.017
  22. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015 Jan 08; 517(7533):205-8.
    View in: PubMed
    Score: 0.017
  23. Monocytes and infection: modulator, messenger and effector. Immunobiology. 2015 Feb; 220(2):210-4.
    View in: PubMed
    Score: 0.017
  24. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014 Aug 14; 124(7):1174-82.
    View in: PubMed
    Score: 0.016
  25. Commensal bacteria mediated defenses against pathogens. Curr Opin Immunol. 2014 Aug; 29:16-22.
    View in: PubMed
    Score: 0.016
  26. Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections. Nat Med. 2014 Mar; 20(3):246-7.
    View in: PubMed
    Score: 0.016
  27. Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns. Mucosal Immunol. 2014 Mar; 7(2):210-4.
    View in: PubMed
    Score: 0.016
  28. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol. 2013 Nov; 13(11):790-801.
    View in: PubMed
    Score: 0.016
  29. Cuffed and exposed--perp-walking bradyrhizobium. N Engl J Med. 2013 Aug 08; 369(6):572-4.
    View in: PubMed
    Score: 0.015
  30. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis. 2013 Aug; 26(4):332-7.
    View in: PubMed
    Score: 0.015
  31. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med. 2013 Mar; 19(3):372-7.
    View in: PubMed
    Score: 0.015
  32. Editorial overview. Curr Opin Immunol. 2012 Aug; 24(4):361-3.
    View in: PubMed
    Score: 0.014
  33. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012 Oct; 55(7):905-14.
    View in: PubMed
    Score: 0.014
  34. Antibiotics, microbiota, and immune defense. Trends Immunol. 2012 Sep; 33(9):459-66.
    View in: PubMed
    Score: 0.014
  35. Innate immune signaling in defense against intestinal microbes. Immunol Rev. 2012 Jan; 245(1):113-31.
    View in: PubMed
    Score: 0.014
  36. Monocyte-mediated immune defense against murine Listeria monocytogenes infection. Adv Immunol. 2012; 113:119-34.
    View in: PubMed
    Score: 0.014
  37. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe. 2011 Oct 20; 10(4):311-23.
    View in: PubMed
    Score: 0.014
  38. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011 Oct 10; 11(11):762-74.
    View in: PubMed
    Score: 0.014
  39. Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol. 2011 Jun; 23(3):353-60.
    View in: PubMed
    Score: 0.013
  40. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010 Dec; 120(12):4332-41.
    View in: PubMed
    Score: 0.013
  41. Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol. 2009 Aug 15; 183(4):2678-87.
    View in: PubMed
    Score: 0.012
  42. Tipping the balance in favor of protective immunity during influenza virus infection. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):4961-2.
    View in: PubMed
    Score: 0.011
  43. Coordinating innate immune cells to optimize microbial killing. Immunity. 2008 Nov 14; 29(5):672-4.
    View in: PubMed
    Score: 0.011
  44. TLR polymorphisms and the risk of invasive fungal infections. N Engl J Med. 2008 Oct 23; 359(17):1836-8.
    View in: PubMed
    Score: 0.011
  45. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis. 2008 Jul 15; 198(2):176-85.
    View in: PubMed
    Score: 0.011
  46. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008; 26:421-52.
    View in: PubMed
    Score: 0.010
  47. Immune responses to commensal and environmental microbes. Nat Immunol. 2007 Nov; 8(11):1173-8.
    View in: PubMed
    Score: 0.010
  48. Cracking the fungal armor. Nat Med. 2006 Jul; 12(7):730-2.
    View in: PubMed
    Score: 0.009
  49. Immunity to fungi. Curr Opin Immunol. 2006 Aug; 18(4):465-72.
    View in: PubMed
    Score: 0.009
  50. Immune responses to Aspergillus fumigatus infections. Biol Blood Marrow Transplant. 2006 Jan; 12(1 Suppl 1):47-9.
    View in: PubMed
    Score: 0.009
  51. Immune responses to Listeria monocytogenes. Nat Rev Immunol. 2004 Oct; 4(10):812-23.
    View in: PubMed
    Score: 0.008
  52. T cell responses to Listeria monocytogenes. Curr Opin Microbiol. 2004 Feb; 7(1):45-50.
    View in: PubMed
    Score: 0.008
  53. Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals. ACS Chem Biol. 2024 Feb 16; 19(2):357-369.
    View in: PubMed
    Score: 0.008
  54. Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration. Nat Microbiol. 2024 Jan; 9(1):55-69.
    View in: PubMed
    Score: 0.008
  55. Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
    View in: PubMed
    Score: 0.008
  56. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
    View in: PubMed
    Score: 0.008
  57. Quantitative studies of CD8+ T-cell responses during microbial infection. Curr Opin Immunol. 2003 Aug; 15(4):436-42.
    View in: PubMed
    Score: 0.008
  58. The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia. Cell Host Microbe. 2023 07 12; 31(7):1126-1139.e6.
    View in: PubMed
    Score: 0.008
  59. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell. 2023 06 08; 186(12):2705-2718.e17.
    View in: PubMed
    Score: 0.008
  60. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature. 2023 01; 613(7945):639-649.
    View in: PubMed
    Score: 0.007
  61. Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.
    View in: PubMed
    Score: 0.007
  62. Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus. J Clin Invest. 2002 Nov; 110(10):1493-501.
    View in: PubMed
    Score: 0.007
  63. Homeostasis of na?ve, effector and memory CD8 T cells. Curr Opin Immunol. 2002 Jun; 14(3):348-53.
    View in: PubMed
    Score: 0.007
  64. A compilation of fecal microbiome shotgun metagenomics from hematopoietic cell transplantation patients. Sci Data. 2022 05 18; 9(1):219.
    View in: PubMed
    Score: 0.007
  65. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med. 2022 04; 28(4):713-723.
    View in: PubMed
    Score: 0.007
  66. CD8 T cell responses to infectious pathogens. Annu Rev Immunol. 2003; 21:29-70.
    View in: PubMed
    Score: 0.007
  67. Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria. Clin Infect Dis. 2021 12 06; 73(11):e4627-e4635.
    View in: PubMed
    Score: 0.007
  68. A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microb Genom. 2021 06; 7(6).
    View in: PubMed
    Score: 0.007
  69. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021 03 18; 137(11):1527-1537.
    View in: PubMed
    Score: 0.007
  70. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data. 2021 03 02; 8(1):71.
    View in: PubMed
    Score: 0.007
  71. Cervicovaginal bacterial communities in reproductive-aged Tanzanian women with Schistosoma mansoni, Schistosoma haematobium, or without schistosome infection. ISME J. 2021 05; 15(5):1539-1550.
    View in: PubMed
    Score: 0.006
  72. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood. 2000 Oct 15; 96(8):2814-21.
    View in: PubMed
    Score: 0.006
  73. The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood. 2020 07 02; 136(1):130-136.
    View in: PubMed
    Score: 0.006
  74. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med. 2020 02 27; 382(9):822-834.
    View in: PubMed
    Score: 0.006
  75. Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):81-89.
    View in: PubMed
    Score: 0.006
  76. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019 12 04; 10(1):5521.
    View in: PubMed
    Score: 0.006
  77. Processing of Listeria monocytogenes antigens and the in vivo T-cell response to bacterial infection. Immunol Rev. 1999 Dec; 172:163-9.
    View in: PubMed
    Score: 0.006
  78. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science. 2019 11 29; 366(6469):1143-1149.
    View in: PubMed
    Score: 0.006
  79. Gastrointestinal pathogen colonization and the microbiome in asymptomatic kidney transplant recipients. Transpl Infect Dis. 2019 Dec; 21(6):e13167.
    View in: PubMed
    Score: 0.006
  80. Butyrate-producing gut bacteria and viral infections in kidney transplant recipients: A pilot study. Transpl Infect Dis. 2019 Dec; 21(6):e13180.
    View in: PubMed
    Score: 0.006
  81. T cell responses to bacterial infection. Curr Opin Immunol. 1999 Aug; 11(4):400-5.
    View in: PubMed
    Score: 0.006
  82. Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood Adv. 2019 07 09; 3(13):2040-2044.
    View in: PubMed
    Score: 0.006
  83. Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination. Infect Immun. 2019 07; 87(7).
    View in: PubMed
    Score: 0.006
  84. Antigen presentation in the immune response to infectious diseases. Clin Infect Dis. 1999 Apr; 28(4):714-6.
    View in: PubMed
    Score: 0.006
  85. The role of CD1-restricted T cells in infectious diseases. Trends Microbiol. 1999 Jan; 7(1):13.
    View in: PubMed
    Score: 0.006
  86. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019 01 07; 216(1):84-98.
    View in: PubMed
    Score: 0.006
  87. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med. 2018 09 26; 10(460).
    View in: PubMed
    Score: 0.005
  88. The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota. Int J Nanomedicine. 2018; 13:5275-5286.
    View in: PubMed
    Score: 0.005
  89. A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity. Sci Transl Med. 2018 08 15; 10(454).
    View in: PubMed
    Score: 0.005
  90. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant. 2019 02; 19(2):488-500.
    View in: PubMed
    Score: 0.005
  91. Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection. J Exp Med. 1998 Jul 06; 188(1):61-70.
    View in: PubMed
    Score: 0.005
  92. Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood. 2018 06 28; 131(26):2978-2986.
    View in: PubMed
    Score: 0.005
  93. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018 04 10; 2(7):745-753.
    View in: PubMed
    Score: 0.005
  94. Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol. 1998; 16:323-58.
    View in: PubMed
    Score: 0.005
  95. Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression. Cancer Res. 2017 11 15; 77(22):6400-6414.
    View in: PubMed
    Score: 0.005
  96. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study. Cancer Causes Control. 2017 Sep; 28(9):959-969.
    View in: PubMed
    Score: 0.005
  97. Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2017 04 01; 215(7):1117-1123.
    View in: PubMed
    Score: 0.005
  98. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol. 2017 May 20; 35(15):1650-1659.
    View in: PubMed
    Score: 0.005
  99. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017 May; 23(5):845-852.
    View in: PubMed
    Score: 0.005
  100. Short- and long-term effects of oral vancomycin on the human intestinal microbiota. J Antimicrob Chemother. 2017 01; 72(1):128-136.
    View in: PubMed
    Score: 0.005
  101. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med. 2016 05 18; 8(339):339ra71.
    View in: PubMed
    Score: 0.005
  102. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint? Clin Infect Dis. 2016 06 15; 62(12):1514-1520.
    View in: PubMed
    Score: 0.005
  103. Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology. J Clin Microbiol. 2016 Jul; 54(7):1686-1693.
    View in: PubMed
    Score: 0.005
  104. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun. 2016 Feb 02; 7:10391.
    View in: PubMed
    Score: 0.005
  105. IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy? Science. 2015 Nov 27; 350(6264):1031-2.
    View in: PubMed
    Score: 0.005
  106. Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant. Infect Control Hosp Epidemiol. 2016 Jan; 37(1):8-15.
    View in: PubMed
    Score: 0.004
  107. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1373-83.
    View in: PubMed
    Score: 0.004
  108. Gut microbiota and tacrolimus dosing in kidney transplantation. PLoS One. 2015; 10(3):e0122399.
    View in: PubMed
    Score: 0.004
  109. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015 Jan; 67(1):128-39.
    View in: PubMed
    Score: 0.004
  110. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014 Oct 15; 98(7):697-705.
    View in: PubMed
    Score: 0.004
  111. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation. PLoS One. 2014; 9(3):e90158.
    View in: PubMed
    Score: 0.004
  112. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife. 2013 Nov 05; 2:e01202.
    View in: PubMed
    Score: 0.004
  113. Cellular immunity to intracellular bacteria. Curr Opin Immunol. 1993 Aug; 5(4):492-6.
    View in: PubMed
    Score: 0.004
  114. Do nonclassical, class Ib MHC molecules present bacterial antigens to T cells? Trends Microbiol. 1993 Apr; 1(1):35-8.
    View in: PubMed
    Score: 0.004
  115. Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One. 2013; 8(1):e54302.
    View in: PubMed
    Score: 0.004
  116. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012 Oct; 64(10):3083-94.
    View in: PubMed
    Score: 0.004
  117. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med. 2012 May 07; 209(5):903-11.
    View in: PubMed
    Score: 0.004
  118. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biol Blood Marrow Transplant. 2010 Nov; 16(11):1576-81.
    View in: PubMed
    Score: 0.003
  119. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010 Apr; 60(4):257-63.
    View in: PubMed
    Score: 0.003
  120. Toll-like receptor 4 polymorphisms and risk of gram-negative bacteremia after allogeneic stem cell transplantation. A prospective pilot study. Biol Blood Marrow Transplant. 2009 Sep; 15(9):1130-3.
    View in: PubMed
    Score: 0.003
  121. Risk factors for late Staphylococcus aureus bacteremia after allogeneic hematopoietic stem cell transplantation: a single-institution, nested case-controlled study. Biol Blood Marrow Transplant. 2008 Dec; 14(12):1429-33.
    View in: PubMed
    Score: 0.003
  122. Clinical characterization of human metapneumovirus infection among patients with cancer. J Infect. 2008 Dec; 57(6):464-71.
    View in: PubMed
    Score: 0.003
  123. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med. 2008 Sep 29; 205(10):2359-68.
    View in: PubMed
    Score: 0.003
  124. Risk factors and attributable mortality of late aspergillosis after T-cell depleted hematopoietic stem cell transplantation. Transpl Infect Dis. 2008 Jun; 10(3):162-7.
    View in: PubMed
    Score: 0.003
  125. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis. 2007 Jun; 9(2):108-13.
    View in: PubMed
    Score: 0.003
  126. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2007 Dec; 9(4):286-94.
    View in: PubMed
    Score: 0.003
  127. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann N Y Acad Sci. 2005 Dec; 1062:95-103.
    View in: PubMed
    Score: 0.002
  128. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2005 Mar; 7(1):11-7.
    View in: PubMed
    Score: 0.002
  129. Prevention of peritransplantation viridans streptococcal bacteremia with early vancomycin administration: a single-center observational cohort study. Clin Infect Dis. 2004 Dec 01; 39(11):1625-32.
    View in: PubMed
    Score: 0.002
  130. In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity. Clin Cancer Res. 2004 Nov 01; 10(21):7207-19.
    View in: PubMed
    Score: 0.002
  131. Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers. Blood. 2004 Oct 15; 104(8):2397-402.
    View in: PubMed
    Score: 0.002
  132. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol. 2004 Jan 15; 172(2):1287-94.
    View in: PubMed
    Score: 0.002
  133. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Blood. 2003 Oct 01; 102(7):2498-505.
    View in: PubMed
    Score: 0.002
  134. Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood. 2003 Jun 01; 101(11):4290-7.
    View in: PubMed
    Score: 0.002
  135. Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest. 2002 Aug; 110(4):537-48.
    View in: PubMed
    Score: 0.002
  136. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Clin Infect Dis. 2002 Aug 01; 35(3):E35-6.
    View in: PubMed
    Score: 0.002
  137. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 2002 Mar 01; 99(5):1730-40.
    View in: PubMed
    Score: 0.002
  138. High-level primary CD8(+) T-cell response to human immunodeficiency virus type 1 gag and env generated by vaccination with recombinant vesicular stomatitis viruses. J Virol. 2002 Mar; 76(6):2730-8.
    View in: PubMed
    Score: 0.002
  139. The CD40-CD154 system in anti-infective host defense. Curr Opin Immunol. 1997 Aug; 9(4):491-7.
    View in: PubMed
    Score: 0.001
  140. A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect Immun. 1996 May; 64(5):1685-93.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.